Login
Manage Portfolio
Post a StockTalk
Write an Instablog
Get Daily Email Alert
Seeking Alpha
Home
The Macro View
Stocks & Sectors
Global Markets
ETFs
Investing Ideas
Breaking News
Transcripts
Business Intelligence
ZymoGenetics, Inc. (ZGEN)
(
)
Quote & Articles
Transcripts
Instablogs
StockTalks
Comments on articles
Cramer
Authors on ZGEN
Newest on ZGEN
Mark Cifra
(1)
EP Vantage
(1)
Andrew Wilkinson
(1)
Mike Havrilla
(1)
Zacks.com
(2)
Most frequent on ZGEN
SA Editor Miriam Metzinger
(
3
)
Centient Biotech Investor
(
3
)
Zacks.com
(
2
)
Mike Havrilla
(
1
)
Andrew Wilkinson
(
1
)
Most followed on ZGEN
Mike Havrilla
(
1130
)
Andrew Wilkinson
(
871
)
Zacks.com
(
594
)
SA Editor Miriam Metzinger
(
301
)
Mark Cifra
(
24
)
Most commented on ZGEN
Mark Cifra
(
5
)
SA Editor Miriam Metzinger
(
3
)
Zacks.com
(
2
)
Mike Havrilla
(
1
)
52wk high:
52wk low:
EPS:
PE:
Dividend:
Yield:
Market Cap:
Exchange:
Articles on ZymoGenetics, Inc. (ZGEN)
by
latest
|
most commented
Q1 2009 Biotech Roundup: The Good, the Bad and the Ugly
Apr 2
•
Mark Cifra
•
CVTX
,
ARNA
,
ACOR
•
5 Comments
|
Quick Read
Failure to Launch for Last Year's Big Pharma and Biotech Hopes
Feb 13
•
EP Vantage
•
ARKTF.PK
,
BMY
,
BYERF.PK
•
Comment!
|
Quick Read
Five Biotech Stocks to Weather a Down Market
Apr 22, 2008
•
Zacks.com
•
EURX
,
BMRN
,
DNDN
•
1 Comment
|
Quick Read
Biotech Stocks: Sector Outlook and Top Picks
Apr 8, 2008
•
Zacks.com
•
GNTA
,
EURX
,
DNDN
•
1 Comment
|
Quick Read
Tuesday's Options Report: UAUA, Adobe, ZGEN, NLS, KWK, WPZ, Best Buy, GS
Dec 18, 2007
•
Andrew Wilkinson
•
GS
,
BBY
,
ADBE
•
Comment!
|
Quick Read
Top 10 Emerging Biotech Stocks
Oct 15, 2007
•
Mike Havrilla
•
ADLS
,
GTCB
,
EXAS
•
1 Comment
|
Quick Read
Biotech Day in Review: Avalon Signs $200 Million Deal with Merck
Mar 8, 2007
•
Centient Biotech Investor
•
CGEN
,
BSTE
,
AVRX
•
Comment!
|
Quick Read
Biotech Stock Review: GPC Biotech Completes New Drug Approval
Feb 20, 2007
•
Centient Biotech Investor
•
GPCB
,
CAPS
,
GILD
•
Comment!
|
Quick Read
Biotech Stocks Day In Review: Alfacell Receives Orphan Drug Status For Onconase
Jan 31, 2007
•
Centient Biotech Investor
•
CGEN
,
ACEL
,
BPA
•
Comment!
|
Quick Read